Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience

Abstract We conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME) study. The primary outcome was mean chang...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matteo Fallico, Andrea Maugeri, Andrew Lotery, Antonio Longo, Vincenza Bonfiglio, Andrea Russo, Teresio Avitabile, Claudio Furino, Gilda Cennamo, Martina Barchitta, Antonella Agodi, Paola Marolo, Luca Ventre, Paolo Caselgrandi, Michele Reibaldi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6e4a5ce518fe424c879b866e62d312c0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!